1. Home
  2. ATRA vs ONMD Comparison

ATRA vs ONMD Comparison

Compare ATRA & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$9.43

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.74

Market Cap

35.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATRA
ONMD
Founded
2012
2006
Country
United States
United States
Employees
N/A
23
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
35.9M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ATRA
ONMD
Price
$9.43
$0.74
Analyst Decision
Sell
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
75.0K
352.0K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
122.52
N/A
EPS
N/A
N/A
Revenue
$120,772,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.92
$0.44
52 Week High
$19.15
$4.22

Technical Indicators

Market Signals
Indicator
ATRA
ONMD
Relative Strength Index (RSI) 43.33 55.45
Support Level $9.03 $0.59
Resistance Level $11.17 $0.96
Average True Range (ATR) 0.80 0.07
MACD -0.24 0.02
Stochastic Oscillator 0.00 91.30

Price Performance

Historical Comparison
ATRA
ONMD

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

Share on Social Networks: